Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
covid-19
7
×
life sciences
national blog main
boston blog main
national
national top stories
san diego blog main
san diego top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
deals
detroit blog main
detroit top stories
europe blog main
europe top stories
fda
indiana blog main
indiana top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
cancer
cancer immunotherapy
cystic fibrosis
eli lilly
gilead sciences
What
bio
roundup
acquisitions
biotech
buy
ceo
covid
daniel
days
debut
gilead
ipo
medicines
o’day
sciences
scientists
treat
way
abbvie’s
abcellera
abcellera’s
ahead
alliance
announced
antibodies
antibody
arranged
based
biggest
biofourmis
biologics
bristol
bucks
build
calls
cancer
capacity
celebrate
chance
changing
Language
unset
Current search:
covid-19
×
biotech
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
UCSD, 5 Diagnostic Makers Partner to Ramp COVID-19 Testing Capacity
@xconomy.com
4 years ago
AbCellera’s Coronavirus “Neutralizing” Antibody Leads Enter Screening
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
